E
Elaborate
Health data delivery software for doctors
About Elaborate
Elaborate is a health tech startup that aims to revolutionize the way patients interact with their lab results and health data. The company provides a platform that partners with doctors to deliver personalized, easy-to-understand reports summarizing lab results. This service is particularly beneficial for patients who want to stay informed about their health in real-time and have historical data to contextualize their results.
Read full description
Elaborate operates in the healthcare technology market, focusing on both patients and healthcare providers. The platform uses a proprietary algorithm to highlight key insights from lab results, making it easier for patients to understand their health status. Additionally, the app offers real-time updates and in-app scheduling to discuss findings with doctors, ensuring that patients can take timely action based on their results.
The business model of Elaborate is likely subscription-based, where healthcare providers or patients pay a recurring fee to access the platform's services. This model ensures a steady revenue stream while providing continuous value to its users. The company makes money by offering a premium service that enhances the patient-doctor interaction, making healthcare more efficient and personalized.
In summary, Elaborate is a health tech startup that partners with doctors to provide personalized lab result reports, real-time updates, and in-app scheduling for consultations. It serves patients and healthcare providers in the healthcare technology market, using a subscription-based business model to generate revenue.
Latest news
Press, funding announcements and product moves mentioning Elaborate.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2023 | $10M | $40M | Founder Collective · Sara Wajnberg · Scott Belsky · Peter Glass | ↗ |
| SEEDEquity / VC | Mar 2022 | $0 | — | Company Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Elaborate is 2K monthly website visits, down 51.2% over the last three months. Elaborate's team declined 2.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed10 investors entered at this stage
Company Ventures
Tusk Ventures
Founder Collective
Sara Wajnberg
Scott Belsky
Peter Glass
Bling Capital
Elliot Cohen
Sean Glass
Arkitekt Ventures
Other known investors2 additional known investors
Enke Bashllari
Pavan Choksi
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elaborate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elaborate’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.